Can the (√n+1) Rule be accepted in Sampling Plans?
Recommendation

17/18 November 2026
Heidelberg, Germany
Enhanced Approach using AQbD Principles
Is a sampling plan based on the (√n+1) rule acceptable for determining the correct number of samples? The Canadian health authority (Health Canada) listed this question in the section "Good Manufacturing Practices (GMP) Questions and Answers" of their website and answered it as follows:
Sampling plans and procedures must be statistically valid and based on scientifically sound sampling practices.
Among the important issues to be considered regarding the risks are:
- the previously determined classification of defects,
- the criticality of the material,
- the previous quality history of the supplier.
A sampling plan based on (√n+1) may generally be acceptable, e.g. for a large number of containers. However, such a sampling plan may pose a considerable risk of accepting defect goods when sampling a small number of containers, for example.
A documented justification is expected for all sampling plans.
Strictly speaking, these requirements only apply for der Canadian market, they can, however, be viewed as state of the art worldwide.
The question with its complete answer can be found in section "Raw Material Testing - C.02.009 & C.02.010" under Q7 - see
"Good Manufacturing Practices (GMP) Questions and Answers / Is the sampling plan based on the (√n+1) acceptable for identifying the number of containers of raw material to be sampled?"
Related GMP News
02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus


